Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)

NCT05465226 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT05465226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05465226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)
Lead sponsor
University of Tennessee
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2023
Completion date
October 24, 2023
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, adverse drug event, burns, nausea and vomiting, postoperative, respiratory depression